Health care from the moment of myocardial infarction is an Achilles heel. However, the subject is not as obscure as it used ...
Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD, discuss the use of beta-blocker therapy following acute MI ...
The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...
A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said ...
The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...
Young patients with myocardial infarction (MI) and fewer traditional risk factors often have greater exposure to urban noise, ...
Sinai Chicago has received the American Heart Association’s Get With The Guidelines® – Coronary Artery Disease NSTEMI Gold ...
The following is a summary of “Angiography-versus wire-based microvascular resistance index to detect coronary microvascular ...
JPI-289 is under clinical development by Jeil Pharmaceutical and currently in Phase II for Myocardial Infarction.
In a large meta-analysis, complete revascularisation reduced cardiovascular events compared with culprit-only revascularisation in older patients with a myocardial infarction and multivessel disease ...
Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal ...